Robotics Expert Brian Miller on Product Development, AI and What He Learned at Intuitive

Why It Matters

Miller’s guidance shows medtech firms how to accelerate AI‑enabled surgical robotics while managing regulatory, data‑sharing, and skill‑retention challenges, directly impacting market adoption and competitive advantage.

Key Takeaways

• Miller stresses observing surgeons in the OR to uncover true needs
• Intraprocedural data must be tied to a clear value hypothesis
• AI in surgery combines video analysis, multimodal models, and edge computing
• Deskilling risk can be mitigated by mandatory manual practice intervals
• Digital teams should prioritize data rights and robust platform foundations

Pulse Analysis

The surgical robotics sector is entering a pivotal growth phase, driven by companies like Sovato that aim to democratize telesurgery. While the hardware advances rapidly, Miller underscores that true innovation stems from deep immersion in the operating room, where engineers can witness the nuanced challenges surgeons face. This user‑centric approach not only informs design but also fuels the data streams needed for sophisticated AI models, positioning firms to capture a larger share of the projected $12 billion market by 2030.

Effective product development now hinges on turning raw intraprocedural data into actionable insight. Miller advocates a "value hypothesis" framework: define the clinical question, align stakeholders, and then collect only the data that proves the hypothesis. This disciplined method eases regulatory scrutiny and mitigates the sensitivity around data sharing, enabling faster iteration cycles. Companies that master this balance can unlock new revenue streams through performance‑based contracts and real‑world evidence studies.

AI’s role in surgery is evolving from basic pattern recognition to multimodal, generative systems that integrate video, sensor, and patient data at the edge. Miller warns that as automation grows, so does the risk of deskilling, echoing aviation’s mandatory manual flight requirements. To counteract this, device makers must embed training protocols and periodic manual overrides into product design. Simultaneously, building in‑house digital expertise—anchored by robust data‑rights policies and scalable platforms—ensures that firms can responsibly harness AI’s potential while maintaining clinician competence. This dual focus on technology and human factors will define the next wave of surgical innovation.